Projects per year
Personal profile
Education
- 1998 Ph.D. Pharmacology, Massachusetts College of Pharmacy and Health Sciences
- 1996 M.S., Pharmacology, Massachusetts College of Pharmacy and Health Sciences
- 1991 B.S., School of Pharmacy, China Medical University
Experience
- 2016- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2016-2017 Associate Professor, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2012-2016 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2008-2012 Associate Professor, School of Pharmacy, Taipei Medical University
- 2002-2008 Assistant Professor, School of Pharmacy, Taipei Medical University
Research Interests
- Biochemistry of cataract, infertility and neurodegenerative diseases
- Therapeutic drug monitoring and clinical pharmacokinetics in psychiatrics and blood disorders
- Pharmaceutical care and managements
Fingerprint
Dive into the research topics where Tzu-Hua Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Application of Therapeutic Drug Monitoring and Omic Technologies to Investigate Factors Regulating Prolactin and Disease Managements
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
刺蒺藜與潼蒺藜粗萃對精子活性差異與鋅鎂濃度的影響
7/1/21 → 2/28/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
枸杞多醣對鐵沉積及其相關病症之影響
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討酵素基因多型性變異及生化營養指標對接受鐵螯合治療之重型海洋性貧血病人心臟鐵質沉積控制成效的影響
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Disturbances of One Carbon Metabolism and Gsk3β Signaling in Depressive Conditions and Effects of Tribulus Terrestris Fruits
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y. A., Wu, T. H., Chen, C. H. & Lu, M. L., Jul 1 2022, In: International journal of molecular sciences. 23, 13, 7092.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus) -
Developing a Sensitive Platform to Measure 5-Methyltetrahydrofolate in Subjects with MTHFR and PON1 Gene Polymorphisms
Lu, M. L., Ku, W. C., Syifa, N., Hu, S. C., Chou, C. T., Wu, Y. H., Kuo, P. H., Chen, C. H., Chen, W. J. & Wu, T. H., Aug 2022, In: Nutrients. 14, 16, 3320.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials
Goh, K. K., Chen, C. H., Wu, T. H., Chiu, Y. H. & Lu, M. L., Aug 22 2022, In: Frontiers in Pharmacology. 13, 944437.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Goh, K. K., Wu, T. H., Chen, C. H. & Lu, M. L., Jan 2021, In: Journal of Psychopharmacology. 35, 3, p. 236-252 17 p.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus) -
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
Wu, T. H., Lin, C. H., Goh, K. K., Chen, C. Y. A., Chen, C. H., Lane, H. Y. & Lu, M. L., Aug 5 2021, In: Frontiers in Pharmacology. 12, 718800.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)
Datasets
-
sj-pdf-1-jop-10.1177_0269881120965937 – Supplemental material for Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Wu, T. (Contributor), Lu, M. (Contributor), Chen, C. (Contributor) & Goh, K. K. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.13547384.v1, https://doi.org/10.25384%2Fsage.13547384.v1
Dataset
-
MOESM2 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Chien, S. (Contributor), Wu, C. (Contributor), Hung, Y. (Creator), Cheng, K. (Contributor), Wu, T. (Contributor), Syifa, N. (Contributor), Lo, P. (Contributor), Lin, S. (Contributor), Hu, S. (Creator), Chen, Y. (Contributor) & Chen, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293076.v1, https://doi.org/10.6084%2Fm9.figshare.11293076.v1
Dataset
-
MOESM1 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Wu, C. (Contributor), Chen, Y. (Contributor), Chen, C. (Contributor), Chien, S. (Contributor), Syifa, N. (Contributor), Hung, Y. (Creator), Cheng, K. (Contributor), Hu, S. (Creator), Lo, P. (Contributor), Lin, S. (Contributor) & Wu, T. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293073.v1, https://springernature.figshare.com/articles/MOESM1_of_Constructing_a_bilingual_website_with_validated_database_for_Herb_and_Western_medicine_interactions_using_Ginseng_Ginkgo_and_Dong_Quai_as_examples/11293073/1
Dataset
-
Efficacy of <i>N</i>-methyl-<i>D</i>-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Wu, T. (Contributor), Lu, M. (Contributor), Goh, K. K. (Contributor) & Chen, C. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.c.5262416.v1, https://doi.org/10.25384%2Fsage.c.5262416.v1
Dataset